Alexion Pharmaceuticals has acquired 9 companies of its own, including 5 in the last 5 years. A total of 1 acquisition came from private equity firms.
Alexion Pharmaceuticals’ largest acquisition to date was in 2015, when it acquired Synageva BioPharma for $8.4B. Alexion Pharmaceuticals has acquired in 3 different US states, and 3 countries. The Company’s most targeted sectors include life science (89%) and healthcare services (12%).
Join Mergr and gain access to Alexion Pharmaceuticals’ M&A summary, the M&A summaries of companies just like it, as well as recent M&A activity in the life science sector.
M&A Total Activity9
- M&A Buy Activity9
- Total Sectors Invested 2
- Total Countries Invested 3
- M&A Buy/Sell Connections 1
- M&A Advisors 9